<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39348396</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>TRIM56 restricts Coxsackievirus B infection by mediating the ubiquitination of viral RNA-dependent RNA polymerase 3D.</ArticleTitle><Pagination><StartPage>e1012594</StartPage><MedlinePgn>e1012594</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1012594</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1012594</ELocationID><Abstract><AbstractText>Coxsackievirus B (CVB) is the major causative pathogen for severe diseases such as viral myocarditis, meningitis, and pancreatitis. There is no effective antiviral therapy currently available for CVB infection primarily due to that the pathogenesis of CVB has not been completely understood. Viruses are obligate intracellular pathogens which subvert cellular processes to ensure viral replication. Dysregulation of ubiquitination has been implicated in CVB infection. However, how ubiquitination is involved in CVB infection remains unclear. Here we found that the 3D protein of CVB3, the RNA-dependent RNA polymerase, was modified at K220 by K48-linked polyubiquitination which promoted its degradation through proteasome. Proteomic analysis showed that the E3 ligase TRIM56 was upregulated in CVB3-infected cells, while the majority of TRIMs remained unchanged. Pull-down and immunoprecipitation analyses showed that TRIM56 interacted with CVB3 3D. Immunofluorescence observation showed that viral 3D protein was colocalized with TRIM56. TRIM56 overexpression resulted in enhanced ubiquitination of CVB3 3D and decreased virus yield. Moreover, TRIM56 was cleaved by viral 3C protease in CVB3-infected cells. Taken together, this study demonstrated that TRIM56 mediates the ubiquitination and proteasomal degradation of the CVB3 3D protein. These findings demonstrate that TRIM56 is an intrinsic cellular restriction factor against CVB infection, and enhancing viral protein degradation could be a potential strategy to control CVB infection.</AbstractText><CopyrightInformation>Copyright: © 2024 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Yanyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luan</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Lexun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Teaching Center of Pathogenic Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Siwei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Danxiang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Jianwei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fei</LastName><ForeName>Yanru</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guangtian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Teaching Center of Pathogenic Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Jiahui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Zhaohua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Wenran</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-2495-5138</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000070584">Tripartite Motif Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.48</RegistryNumber><NameOfSubstance UI="D012324">RNA-Dependent RNA Polymerase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C554560">TRIM56 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="Y">Ubiquitination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="Y">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000070584" MajorTopicYN="Y">Tripartite Motif Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012324" MajorTopicYN="Y">RNA-Dependent RNA Polymerase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>18</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39348396</ArticleId><ArticleId IdType="pmc">PMC11476688</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1012594</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-24-00630</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bouin A, Gretteau PA, Wehbe M, Renois F, N’Guyen Y, Leveque N, et al.. Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5’ Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities. Circulation. 2019;139(20):2326–38. Epub 2019/02/14. doi: 10.1161/CIRCULATIONAHA.118.035966 ; PubMed Central PMCID: PMC6517084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.035966</ArticleId><ArticleId IdType="pmc">PMC6517084</ArticleId><ArticleId IdType="pubmed">30755025</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi FS, Marchant D, Hendry R, Luo H, Yang D, Ye X, et al.. Coxsackievirus B3 replication and pathogenesis. Future Microbiol. 2015;10(4):629–53. Epub 2015/04/14. doi: 10.2217/fmb.15.5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.5</ArticleId><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Yajima T. Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection. Future Microbiol. 2011;6(5):551–66. Epub 2011/05/19. doi: 10.2217/fmb.11.40 ; PubMed Central PMCID: PMC3131135.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.11.40</ArticleId><ArticleId IdType="pmc">PMC3131135</ArticleId><ArticleId IdType="pubmed">21585262</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, Yan D, Song Y, Zhu S, He Y, Han Z, et al.. Whole-genome analysis of coxsackievirus B3 reflects its genetic diversity in China and worldwide. Virol J. 2022;19(1):69. Epub 2022/04/20. doi: 10.1186/s12985-022-01796-0 ; PubMed Central PMCID: PMC9014606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01796-0</ArticleId><ArticleId IdType="pmc">PMC9014606</ArticleId><ArticleId IdType="pubmed">35436962</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaaloul I, Riabi S, Harrath R, Hunter T, Hamda KB, Ghzala AB, et al.. Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients. Mol Med Rep. 2014;10(6):2811–8. Epub 2014/09/23. doi: 10.3892/mmr.2014.2578 ; PubMed Central PMCID: PMC4227425.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2014.2578</ArticleId><ArticleId IdType="pmc">PMC4227425</ArticleId><ArticleId IdType="pubmed">25241846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemball CC, Alirezaei M, Whitton JL. Type B coxsackieviruses and their interactions with the innate and adaptive immune systems. Future Microbiol. 2010;5(9):1329–47. Epub 2010/09/24. doi: 10.2217/fmb.10.101 ; PubMed Central PMCID: PMC3045535.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.10.101</ArticleId><ArticleId IdType="pmc">PMC3045535</ArticleId><ArticleId IdType="pubmed">20860480</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L, Lin L, Zhao W, Wang B, Wu S, Liu H, et al.. Destabilization of coxsackievirus b3 genome integrated with enhanced green fluorescent protein gene. Intervirology. 2011;54(5):268–75. Epub 2011/01/19. doi: 10.1159/000321351 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000321351</ArticleId><ArticleId IdType="pubmed">21242657</ArticleId></ArticleIdList></Reference><Reference><Citation>Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26(4):399–422. Epub 2016/03/26. doi: 10.1038/cr.2016.39 ; PubMed Central PMCID: PMC4822133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2016.39</ArticleId><ArticleId IdType="pmc">PMC4822133</ArticleId><ArticleId IdType="pubmed">27012465</ArticleId></ArticleIdList></Reference><Reference><Citation>Haakonsen DL, Rape M. Branching Out: Improved Signaling by Heterotypic Ubiquitin Chains. Trends Cell Biol. 2019;29(9):704–16. Epub 2019/07/14. doi: 10.1016/j.tcb.2019.06.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2019.06.003</ArticleId><ArticleId IdType="pubmed">31300189</ArticleId></ArticleIdList></Reference><Reference><Citation>Damgaard RB. The ubiquitin system: from cell signalling to disease biology and new therapeutic opportunities. Cell death and differentiation. 2021;28(2):423–6. Epub 2021/01/16. doi: 10.1038/s41418-020-00703-w ; PubMed Central PMCID: PMC7862391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00703-w</ArticleId><ArticleId IdType="pmc">PMC7862391</ArticleId><ArticleId IdType="pubmed">33446876</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng N, Shabek N. Ubiquitin Ligases: Structure, Function, and Regulation. Annu Rev Biochem. 2017;86:129–57. Epub 2017/04/05. doi: 10.1146/annurev-biochem-060815-014922 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060815-014922</ArticleId><ArticleId IdType="pubmed">28375744</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraldo MI, Xia H, Aguilera-Aguirre L, Hage A, van Tol S, Shan C, et al.. Envelope protein ubiquitination drives entry and pathogenesis of Zika virus. Nature. 2020;585(7825):414–9. Epub 2020/07/10. doi: 10.1038/s41586-020-2457-8 ; PubMed Central PMCID: PMC7501154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2457-8</ArticleId><ArticleId IdType="pmc">PMC7501154</ArticleId><ArticleId IdType="pubmed">32641828</ArticleId></ArticleIdList></Reference><Reference><Citation>Valerdi KM, Hage A, van Tol S, Rajsbaum R, Giraldo MI. The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses. Viruses. 2021;13(3). Epub 2021/03/04. doi: 10.3390/v13030369 ; PubMed Central PMCID: PMC7996891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030369</ArticleId><ArticleId IdType="pmc">PMC7996891</ArticleId><ArticleId IdType="pubmed">33652634</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, et al.. Evasion of Type I Interferon by SARS-CoV-2. Cell reports. 2020;33(1):108234. Epub 2020/09/28. doi: 10.1016/j.celrep.2020.108234 ; PubMed Central PMCID: PMC7501843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Si X, McManus BM, Zhang J, Yuan J, Cheung C, Esfandiarei M, et al.. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway. Journal of virology. 2005;79(13):8014–23. Epub 2005/06/16. doi: 10.1128/JVI.79.13.8014-8023.2005 ; PubMed Central PMCID: PMC1143712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.13.8014-8023.2005</ArticleId><ArticleId IdType="pmc">PMC1143712</ArticleId><ArticleId IdType="pubmed">15956547</ArticleId></ArticleIdList></Reference><Reference><Citation>Si X, Wang Y, Wong J, Zhang J, McManus BM, Luo H. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. Journal of virology. 2007;81(7):3142–50. Epub 2007/01/19. doi: 10.1128/JVI.02028-06 ; PubMed Central PMCID: PMC1866032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02028-06</ArticleId><ArticleId IdType="pmc">PMC1866032</ArticleId><ArticleId IdType="pubmed">17229707</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss M, Braun V, Bredow C, Kloetzel PM, Beling A. Coxsackievirus B3 Exploits the Ubiquitin-Proteasome System to Facilitate Viral Replication. Viruses. 2021;13(7). Epub 2021/08/11. doi: 10.3390/v13071360 ; PubMed Central PMCID: PMC8310229.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13071360</ArticleId><ArticleId IdType="pmc">PMC8310229</ArticleId><ArticleId IdType="pubmed">34372566</ArticleId></ArticleIdList></Reference><Reference><Citation>Hage A, Rajsbaum R. To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system. J Gen Virol. 2019;100(12):1641–62. Epub 2019/10/30. doi: 10.1099/jgv.0.001341 ; PubMed Central PMCID: PMC7011758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001341</ArticleId><ArticleId IdType="pmc">PMC7011758</ArticleId><ArticleId IdType="pubmed">31661051</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajsbaum R, Garcia-Sastre A, Versteeg GA. TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. J Mol Biol. 2014;426(6):1265–84. Epub 2013/12/18. doi: 10.1016/j.jmb.2013.12.005 ; PubMed Central PMCID: PMC3945521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.12.005</ArticleId><ArticleId IdType="pmc">PMC3945521</ArticleId><ArticleId IdType="pubmed">24333484</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Z, Wei L, Yu ZB, Yao ZY, Cheng J, Wang YT, et al.. The Roles of TRIMs in Antiviral Innate Immune Signaling. Front Cell Infect Microbiol. 2021;11:628275. Epub 2021/04/02. doi: 10.3389/fcimb.2021.628275 ; PubMed Central PMCID: PMC8005608.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.628275</ArticleId><ArticleId IdType="pmc">PMC8005608</ArticleId><ArticleId IdType="pubmed">33791238</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraldo MI, Hage A, van Tol S, Rajsbaum R. TRIM Proteins in Host Defense and Viral Pathogenesis. Curr Clin Microbiol Rep. 2020;7(4):101–14. Epub 2020/08/25. doi: 10.1007/s40588-020-00150-8 ; PubMed Central PMCID: PMC7414267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40588-020-00150-8</ArticleId><ArticleId IdType="pmc">PMC7414267</ArticleId><ArticleId IdType="pubmed">32837832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozato K, Shin DM, Chang TH, Morse HC 3rd. TRIM family proteins and their emerging roles in innate immunity. Nature reviews Immunology. 2008;8(11):849–60. Epub 2008/10/07. doi: 10.1038/nri2413 ; PubMed Central PMCID: PMC3433745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2413</ArticleId><ArticleId IdType="pmc">PMC3433745</ArticleId><ArticleId IdType="pubmed">18836477</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gent M, Sparrer KMJ, Gack MU. TRIM Proteins and Their Roles in Antiviral Host Defenses. Annu Rev Virol. 2018;5(1):385–405. Epub 2018/06/28. doi: 10.1146/annurev-virology-092917-043323 ; PubMed Central PMCID: PMC6186430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-092917-043323</ArticleId><ArticleId IdType="pmc">PMC6186430</ArticleId><ArticleId IdType="pubmed">29949725</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z, Zhu Z. The role of TRIM proteins in PRR signaling pathways and immune-related diseases. Int Immunopharmacol. 2021;98:107813. Epub 2021/06/15. doi: 10.1016/j.intimp.2021.107813 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107813</ArticleId><ArticleId IdType="pubmed">34126340</ArticleId></ArticleIdList></Reference><Reference><Citation>Toka FN, Dunaway K, Smaltz F, Szulc-Dabrowska L, Drnevich J, Mielcarska MB, et al.. Bacterial and viral pathogen-associated molecular patterns induce divergent early transcriptomic landscapes in a bovine macrophage cell line. BMC Genomics. 2019;20(1):15. Epub 2019/01/10. doi: 10.1186/s12864-018-5411-5 ; PubMed Central PMCID: PMC6323673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-018-5411-5</ArticleId><ArticleId IdType="pmc">PMC6323673</ArticleId><ArticleId IdType="pubmed">30621583</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatakeyama S. TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis. Trends Biochem Sci. 2017;42(4):297–311. Epub 2017/01/26. doi: 10.1016/j.tibs.2017.01.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2017.01.002</ArticleId><ArticleId IdType="pubmed">28118948</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W, Wu M, Qian S, Zhou Y, Chen H, Li X, et al.. TRIM52 inhibits Japanese Encephalitis Virus replication by degrading the viral NS2A. Scientific reports. 2016;6:33698. Epub 2016/09/27. doi: 10.1038/srep33698 ; PubMed Central PMCID: PMC5035999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33698</ArticleId><ArticleId IdType="pmc">PMC5035999</ArticleId><ArticleId IdType="pubmed">27667714</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Huan C, Wang H, Liu Y, Liu X, Su X, et al.. TRIM21-mediated proteasomal degradation of SAMHD1 regulates its antiviral activity. EMBO Rep. 2020;21(1):e47528. Epub 2019/12/05. doi: 10.15252/embr.201847528 ; PubMed Central PMCID: PMC6944907.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201847528</ArticleId><ArticleId IdType="pmc">PMC6944907</ArticleId><ArticleId IdType="pubmed">31797533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Wang X, Chen Z, Deng T, Yan Y, Dong W, et al.. TRIM21 restricts influenza A virus replication by ubiquitination-dependent degradation of M1. PLoS Pathog. 2023;19(6):e1011472. Epub 2023/06/21. doi: 10.1371/journal.ppat.1011472 ; PubMed Central PMCID: PMC10325077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011472</ArticleId><ArticleId IdType="pmc">PMC10325077</ArticleId><ArticleId IdType="pubmed">37343022</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao H, Li J, Yang X, Li Z, Wang Y, Rui Y, et al.. Ectopic Expression of TRIM25 Restores RIG-I Expression and IFN Production Reduced by Multiple Enteroviruses 3C(pro). Virol Sin. 2021;36(6):1363–74. Epub 2021/06/26. doi: 10.1007/s12250-021-00410-x ; PubMed Central PMCID: PMC8226358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-021-00410-x</ArticleId><ArticleId IdType="pmc">PMC8226358</ArticleId><ArticleId IdType="pubmed">34170466</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu S, Li C, Li L, Deng YQ, Chen X, Luo D, et al.. TRIM22 suppresses Zika virus replication by targeting NS1 and NS3 for proteasomal degradation. Cell Biosci. 2022;12(1):139. Epub 2022/08/31. doi: 10.1186/s13578-022-00872-w ; PubMed Central PMCID: PMC9429444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-022-00872-w</ArticleId><ArticleId IdType="pmc">PMC9429444</ArticleId><ArticleId IdType="pubmed">36042495</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Li NL, Wang J, Shi PY, Wang T, Miller MA, et al.. Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus. Journal of virology. 2014;88(23):13821–35. Epub 2014/09/26. doi: 10.1128/JVI.02505-14 ; PubMed Central PMCID: PMC4248981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02505-14</ArticleId><ArticleId IdType="pmc">PMC4248981</ArticleId><ArticleId IdType="pubmed">25253338</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Li NL, Shen Y, Bao X, Fabrizio T, Elbahesh H, et al.. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis. Journal of virology. 2016;90(9):4369–82. Epub 2016/02/19. doi: 10.1128/JVI.03172-15 ; PubMed Central PMCID: PMC4836312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03172-15</ArticleId><ArticleId IdType="pmc">PMC4836312</ArticleId><ArticleId IdType="pubmed">26889027</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D, Li NL, Wei D, Liu B, Guo F, Elbahesh H, et al.. The E3 ligase TRIM56 is a host restriction factor of Zika virus and depends on its RNA-binding activity but not miRNA regulation, for antiviral function. PLoS Negl Trop Dis. 2019;13(6):e0007537. Epub 2019/06/30. doi: 10.1371/journal.pntd.0007537 ; PubMed Central PMCID: PMC6623546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007537</ArticleId><ArticleId IdType="pmc">PMC6623546</ArticleId><ArticleId IdType="pubmed">31251739</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu H, Jan Fada B. Specificity in Ubiquitination Triggered by Virus Infection. Int J Mol Sci. 2020;21(11). Epub 2020/06/12. doi: 10.3390/ijms21114088 ; PubMed Central PMCID: PMC7313089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21114088</ArticleId><ArticleId IdType="pmc">PMC7313089</ArticleId><ArticleId IdType="pubmed">32521668</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharaj P, Atkins C, Luthra P, Giraldo MI, Dawes BE, Miorin L, et al.. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication. Journal of virology. 2017;91(18). Epub 2017/07/07. doi: 10.1128/JVI.00833-17 ; PubMed Central PMCID: PMC5571272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00833-17</ArticleId><ArticleId IdType="pmc">PMC5571272</ArticleId><ArticleId IdType="pubmed">28679761</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim M, Biquand E, Declercq M, Jacob Y, van der Werf S, Demeret C. Nonproteolytic K29-Linked Ubiquitination of the PB2 Replication Protein of Influenza A Viruses by Proviral Cullin 4-Based E3 Ligases. mBio. 2020;11(2). Epub 2020/04/09. doi: 10.1128/mBio.00305-20 ; PubMed Central PMCID: PMC7157767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00305-20</ArticleId><ArticleId IdType="pmc">PMC7157767</ArticleId><ArticleId IdType="pubmed">32265326</ArticleId></ArticleIdList></Reference><Reference><Citation>Chathuranga K, Weerawardhana A, Dodantenna N, Lee JS. Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing. Exp Mol Med. 2021;53(11):1647–68. Epub 2021/11/17. doi: 10.1038/s12276-021-00691-y ; PubMed Central PMCID: PMC8592830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00691-y</ArticleId><ArticleId IdType="pmc">PMC8592830</ArticleId><ArticleId IdType="pubmed">34782737</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaacson MK, Ploegh HL. Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection. Cell host &amp; microbe. 2009;5(6):559–70. Epub 2009/06/17. doi: 10.1016/j.chom.2009.05.012 ; PubMed Central PMCID: PMC7103382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.05.012</ArticleId><ArticleId IdType="pmc">PMC7103382</ArticleId><ArticleId IdType="pubmed">19527883</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang W, Harris KS, Alexander L, Wimmer E. Interaction between the 5’-terminal cloverleaf and 3AB/3CDpro of poliovirus is essential for RNA replication. Journal of virology. 1995;69(6):3658–67. Epub 1995/06/01. doi: 10.1128/JVI.69.6.3658-3667.1995 ; PubMed Central PMCID: PMC189081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.6.3658-3667.1995</ArticleId><ArticleId IdType="pmc">PMC189081</ArticleId><ArticleId IdType="pubmed">7745714</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura N, Semler BL, Rothberg PG, Larsen GR, Adler CJ, Dorner AJ, et al.. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature. 1981;291(5816):547–53. Epub 1981/06/18. doi: 10.1038/291547a0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/291547a0</ArticleId><ArticleId IdType="pubmed">6264310</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron CE, Oh HS, Moustafa IM. Expanding knowledge of P3 proteins in the poliovirus lifecycle. Future Microbiol. 2010;5(6):867–81. Epub 2010/06/05. doi: 10.2217/fmb.10.40 ; PubMed Central PMCID: PMC2904470.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.10.40</ArticleId><ArticleId IdType="pmc">PMC2904470</ArticleId><ArticleId IdType="pubmed">20521933</ArticleId></ArticleIdList></Reference><Reference><Citation>Spear A, Ogram SA, Morasco BJ, Smerage LE, Flanegan JB. Viral precursor protein P3 and its processed products perform discrete and essential functions in the poliovirus RNA replication complex. Virology. 2015;485:492–501. Epub 2015/08/26. doi: 10.1016/j.virol.2015.07.018 ; PubMed Central PMCID: PMC4780368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.07.018</ArticleId><ArticleId IdType="pmc">PMC4780368</ArticleId><ArticleId IdType="pubmed">26303005</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P, Duong DM, Seyfried NT, Cheng D, Xie Y, Robert J, et al.. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell. 2009;137(1):133–45. Epub 2009/04/07. doi: 10.1016/j.cell.2009.01.041 ; PubMed Central PMCID: PMC2668214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.01.041</ArticleId><ArticleId IdType="pmc">PMC2668214</ArticleId><ArticleId IdType="pubmed">19345192</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziv I, Matiuhin Y, Kirkpatrick DS, Erpapazoglou Z, Leon S, Pantazopoulou M, et al.. A perturbed ubiquitin landscape distinguishes between ubiquitin in trafficking and in proteolysis. Mol Cell Proteomics. 2011;10(5):M111 009753. Epub 2011/03/24. doi: 10.1074/mcp.M111.009753 ; PubMed Central PMCID: PMC3098606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M111.009753</ArticleId><ArticleId IdType="pmc">PMC3098606</ArticleId><ArticleId IdType="pubmed">21427232</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchil PD, Hinz A, Siegel S, Coenen-Stass A, Pertel T, Luban J, et al.. TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. Journal of virology. 2013;87(1):257–72. Epub 2012/10/19. doi: 10.1128/JVI.01804-12 ; PubMed Central PMCID: PMC3536418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01804-12</ArticleId><ArticleId IdType="pmc">PMC3536418</ArticleId><ArticleId IdType="pubmed">23077300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Liu B, Wang N, Lee YM, Liu C, Li K. TRIM56 is a virus- and interferon-inducible E3 ubiquitin ligase that restricts pestivirus infection. Journal of virology. 2011;85(8):3733–45. Epub 2011/02/04. doi: 10.1128/JVI.02546-10 ; PubMed Central PMCID: PMC3126137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02546-10</ArticleId><ArticleId IdType="pmc">PMC3126137</ArticleId><ArticleId IdType="pubmed">21289118</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhao S, Chen Y, Wang T, Dong C, Wo X, et al.. The Capsid Protein VP1 of Coxsackievirus B Induces Cell Cycle Arrest by Up-Regulating Heat Shock Protein 70. Frontiers in microbiology. 2019;10:1633. Epub 2019/08/06. doi: 10.3389/fmicb.2019.01633 ; PubMed Central PMCID: PMC6653663.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01633</ArticleId><ArticleId IdType="pmc">PMC6653663</ArticleId><ArticleId IdType="pubmed">31379784</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, et al.. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 2011;7(3):e1001311. Epub 2011/03/26. doi: 10.1371/journal.ppat.1001311 ; PubMed Central PMCID: PMC3059221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001311</ArticleId><ArticleId IdType="pmc">PMC3059221</ArticleId><ArticleId IdType="pubmed">21436888</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin U, Jarasch N, Nestler M, Rassmann A, Munder T, Seitz S, et al.. Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3. Apoptosis: an international journal on programmed cell death. 2007;12(3):525–33. Epub 2007/01/11. doi: 10.1007/s10495-006-0015-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-006-0015-y</ArticleId><ArticleId IdType="pubmed">17211569</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen OH, Svedin E, Kapell S, Nurminen A, Hytonen VP, Flodstrom-Tullberg M. Enteroviral proteases: structure, host interactions and pathogenicity. Rev Med Virol. 2016;26(4):251–67. Epub 2016/05/05. doi: 10.1002/rmv.1883 ; PubMed Central PMCID: PMC7169145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1883</ArticleId><ArticleId IdType="pmc">PMC7169145</ArticleId><ArticleId IdType="pubmed">27145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Park ES, Dezhbord M, Lee AR, Kim KH. The Roles of Ubiquitination in Pathogenesis of Influenza Virus Infection. Int J Mol Sci. 2022;23(9). Epub 2022/05/15. doi: 10.3390/ijms23094593 ; PubMed Central PMCID: PMC9105177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23094593</ArticleId><ArticleId IdType="pmc">PMC9105177</ArticleId><ArticleId IdType="pubmed">35562987</ArticleId></ArticleIdList></Reference><Reference><Citation>Si X, Gao G, Wong J, Wang Y, Zhang J, Luo H. Ubiquitination is required for effective replication of coxsackievirus B3. PloS one. 2008;3(7):e2585. Epub 2008/07/10. doi: 10.1371/journal.pone.0002585 ; PubMed Central PMCID: PMC2440516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002585</ArticleId><ArticleId IdType="pmc">PMC2440516</ArticleId><ArticleId IdType="pubmed">18612413</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraldo MI, Vargas-Cuartas O, Gallego-Gomez JC, Shi PY, Padilla-Sanabria L, Castano-Osorio JC, et al.. K48-linked polyubiquitination of dengue virus NS1 protein inhibits its interaction with the viral partner NS4B. Virus research. 2018;246:1–11. Epub 2018/01/03. doi: 10.1016/j.virusres.2017.12.013 ; PubMed Central PMCID: PMC5811335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2017.12.013</ArticleId><ArticleId IdType="pmc">PMC5811335</ArticleId><ArticleId IdType="pubmed">29294313</ArticleId></ArticleIdList></Reference><Reference><Citation>Koepke L, Gack MU, Sparrer KM. The antiviral activities of TRIM proteins. Curr Opin Microbiol. 2021;59:50–7. Epub 2020/08/24. doi: 10.1016/j.mib.2020.07.005 ; PubMed Central PMCID: PMC7440025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2020.07.005</ArticleId><ArticleId IdType="pmc">PMC7440025</ArticleId><ArticleId IdType="pubmed">32829025</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao G, Zhang J, Si X, Wong J, Cheung C, McManus B, et al.. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice. Am J Physiol Heart Circ Physiol. 2008;295(1):H401–8. Epub 2008/06/03. doi: 10.1152/ajpheart.00292.2008 ; PubMed Central PMCID: PMC2494750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00292.2008</ArticleId><ArticleId IdType="pmc">PMC2494750</ArticleId><ArticleId IdType="pubmed">18515649</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Zhang J, Cheung C, Suarez A, McManus BM, Yang D. Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes. Am J Pathol. 2003;163(2):381–5. Epub 2003/07/24. doi: 10.1016/S0002-9440(10)63667-X ; PubMed Central PMCID: PMC1868224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)63667-X</ArticleId><ArticleId IdType="pmc">PMC1868224</ArticleId><ArticleId IdType="pubmed">12875959</ArticleId></ArticleIdList></Reference><Reference><Citation>Putnak JR, Phillips BA. Picornaviral structure and assembly. Microbiol Rev. 1981;45(2):287–315. Epub 1981/06/01. doi: 10.1128/mr.45.2.287-315.1981 ; PubMed Central PMCID: PMC281510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mr.45.2.287-315.1981</ArticleId><ArticleId IdType="pmc">PMC281510</ArticleId><ArticleId IdType="pubmed">7022155</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyoda H, Nicklin MJ, Murray MG, Anderson CW, Dunn JJ, Studier FW, et al.. A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell. 1986;45(5):761–70. Epub 1986/06/06. doi: 10.1016/0092-8674(86)90790-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(86)90790-7</ArticleId><ArticleId IdType="pubmed">3011278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ypma-Wong MF, Dewalt PG, Johnson VH, Lamb JG, Semler BL. Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology. 1988;166(1):265–70. Epub 1988/09/01. doi: 10.1016/0042-6822(88)90172-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(88)90172-9</ArticleId><ArticleId IdType="pubmed">2842953</ArticleId></ArticleIdList></Reference><Reference><Citation>Yau R, Rape M. The increasing complexity of the ubiquitin code. Nat Cell Biol. 2016;18(6):579–86. Epub 2016/05/28. doi: 10.1038/ncb3358 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3358</ArticleId><ArticleId IdType="pubmed">27230526</ArticleId></ArticleIdList></Reference><Reference><Citation>George AJ, Hoffiz YC, Charles AJ, Zhu Y, Mabb AM. A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders. Front Genet. 2018;9:29. Epub 2018/03/02. doi: 10.3389/fgene.2018.00029 ; PubMed Central PMCID: PMC5817383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00029</ArticleId><ArticleId IdType="pmc">PMC5817383</ArticleId><ArticleId IdType="pubmed">29491882</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M, Saeki Y, Takahashi H, Ohtake F, Yoshida Y, Kasuga Y, et al.. A substrate-trapping strategy to find E3 ubiquitin ligase substrates identifies Parkin and TRIM28 targets. Commun Biol. 2020;3(1):592. Epub 2020/10/22. doi: 10.1038/s42003-020-01328-y ; PubMed Central PMCID: PMC7576197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-020-01328-y</ArticleId><ArticleId IdType="pmc">PMC7576197</ArticleId><ArticleId IdType="pubmed">33082525</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Wang R, Li K. Impaired Antiviral Responses to Extracellular Double-Stranded RNA and Cytosolic DNA, but Not to Interferon-alpha Stimulation, in TRIM56-Deficient Cells. Viruses. 2022;14(1). Epub 2022/01/23. doi: 10.3390/v14010089 ; PubMed Central PMCID: PMC8777648.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14010089</ArticleId><ArticleId IdType="pmc">PMC8777648</ArticleId><ArticleId IdType="pubmed">35062293</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu BM, Li NL, Wang R, Li X, Li ZA, Marion TN, et al.. Key roles for phosphorylation and the Coiled-coil domain in TRIM56-mediated positive regulation of TLR3-TRIF-dependent innate immunity. The Journal of biological chemistry. 2024;300(5):107249. Epub 2024/04/01. doi: 10.1016/j.jbc.2024.107249 ; PubMed Central PMCID: PMC11067339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2024.107249</ArticleId><ArticleId IdType="pmc">PMC11067339</ArticleId><ArticleId IdType="pubmed">38556084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zou W, Niu Y, Wang S, Chen B, Xiong R, et al.. Phosphorylation of enteroviral 2A(pro) at Ser/Thr125 benefits its proteolytic activity and viral pathogenesis. Journal of medical virology. 2023;95(1):e28400. Epub 2022/12/14. doi: 10.1002/jmv.28400 ; PubMed Central PMCID: PMC10107306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28400</ArticleId><ArticleId IdType="pmc">PMC10107306</ArticleId><ArticleId IdType="pubmed">36511115</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim BK, Nam JH, Gil CO, Yun SH, Choi JH, Kim DK, et al.. Coxsackievirus B3 replication is related to activation of the late extracellular signal-regulated kinase (ERK) signal. Virus research. 2005;113(2):153–7. Epub 2005/07/05. doi: 10.1016/j.virusres.2005.04.018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2005.04.018</ArticleId><ArticleId IdType="pubmed">15993506</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo GJ, Kim C, Shin WJ, Sklan EH, Eoh H, Jung JU. TRIM56-mediated monoubiquitination of cGAS for cytosolic DNA sensing. Nature communications. 2018;9(1):613. Epub 2018/02/11. doi: 10.1038/s41467-018-02936-3 ; PubMed Central PMCID: PMC5807518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-02936-3</ArticleId><ArticleId IdType="pmc">PMC5807518</ArticleId><ArticleId IdType="pubmed">29426904</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, Li NL, Wang J, Liu B, Lester S, Li K. TRIM56 is an essential component of the TLR3 antiviral signaling pathway. The Journal of biological chemistry. 2012;287(43):36404–13. Epub 2012/09/06. doi: 10.1074/jbc.M112.397075 ; PubMed Central PMCID: PMC3476306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.397075</ArticleId><ArticleId IdType="pmc">PMC3476306</ArticleId><ArticleId IdType="pubmed">22948160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessely R, Klingel K, Knowlton KU, Kandolf R. Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation. 2001;103(5):756–61. Epub 2001/02/07. doi: 10.1161/01.cir.103.5.756 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.103.5.756</ArticleId><ArticleId IdType="pubmed">11156890</ArticleId></ArticleIdList></Reference><Reference><Citation>Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN. Protective role for interferon-beta in coxsackievirus B3 infection. Circulation. 2004;110(23):3540–3. Epub 2004/07/14. doi: 10.1161/01.CIR.0000136824.73458.20 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000136824.73458.20</ArticleId><ArticleId IdType="pubmed">15249500</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode MF, Schmedes CM, Egnatz GJ, Bharathi V, Hisada YM, Martinez D, et al.. Cell type-specific roles of PAR1 in Coxsackievirus B3 infection. Scientific reports. 2021;11(1):14264. Epub 2021/07/14. doi: 10.1038/s41598-021-93759-8 ; PubMed Central PMCID: PMC8275627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93759-8</ArticleId><ArticleId IdType="pmc">PMC8275627</ArticleId><ArticleId IdType="pubmed">34253819</ArticleId></ArticleIdList></Reference><Reference><Citation>Riad A, Westermann D, Zietsch C, Savvatis K, Becher PM, Bereswill S, et al.. TRIF is a critical survival factor in viral cardiomyopathy. J Immunol. 2011;186(4):2561–70. Epub 2011/01/18. doi: 10.4049/jimmunol.1002029 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1002029</ArticleId><ArticleId IdType="pubmed">21239721</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Wu Y, Qin Y, Hu J, Xie W, Qin FX, et al.. Broad and diverse mechanisms used by deubiquitinase family members in regulating the type I interferon signaling pathway during antiviral responses. Sci Adv. 2018;4(5):eaar2824. Epub 2018/05/08. doi: 10.1126/sciadv.aar2824 ; PubMed Central PMCID: PMC5931765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aar2824</ArticleId><ArticleId IdType="pmc">PMC5931765</ArticleId><ArticleId IdType="pubmed">29732405</ArticleId></ArticleIdList></Reference><Reference><Citation>Mevissen TET, Komander D. Mechanisms of Deubiquitinase Specificity and Regulation. Annu Rev Biochem. 2017;86:159–92. Epub 2017/05/13. doi: 10.1146/annurev-biochem-061516-044916 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-061516-044916</ArticleId><ArticleId IdType="pubmed">28498721</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zheng Z, Shu B, Meng J, Zhang Y, Zheng C, et al.. SUMO Modification Stabilizes Enterovirus 71 Polymerase 3D To Facilitate Viral Replication. Journal of virology. 2016;90(23):10472–85. Epub 2016/09/16. doi: 10.1128/JVI.01756-16 ; PubMed Central PMCID: PMC5110190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01756-16</ArticleId><ArticleId IdType="pmc">PMC5110190</ArticleId><ArticleId IdType="pubmed">27630238</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8. Epub 2002/02/16. doi: 10.1006/meth.2001.1262 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>